Cryoglobulinemia and double-filtration plasmapheresis : Personal experience and literature review
© 2022 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis..
BACKGROUND: Cryoglobulinemia is defined as the presence of an abnormal immunoglobulin that may be responsible for vasculitis of small-caliber vessels. Apheresis can be used in order to temporarily eliminate circulating cryoglobulins. The aim of this study was to assess the effectiveness of apheresis (double-filtration plasmapheresis-DFPP-) in symptomatic and/or severe cryoglobulinemias.
METHODS: Four male patients presenting cryoglobulinemic vasculitis and who received DFPP sessions were included.
RESULTS: Their mean age was 57 ± 15 years. One patient had hepatitis-C virus (HCV)-related cryoglobulinemia and the other three patients were carriers of an IgM Kappa monoclonal gammopathy. Mean duration of follow-up was 15 ± 2 months. DFPP allowed healing of ulcerative skin lesions in the first patient and remission of nephrotic syndrome in the other patients after a median of 6(5-10) sessions.
CONCLUSION: DFPP can be used safely in cryoglobulinemic-vasculitis and can be considered early to achieve a faster and sustained clinical-biological response.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy - 27(2023), 1 vom: 01. Feb., Seite 159-169 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Naciri Bennani, Hamza [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic hepatitis C |
|---|
| Anmerkungen: |
Date Completed 04.01.2023 Date Revised 12.04.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/1744-9987.13885 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341059714 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341059714 | ||
| 003 | DE-627 | ||
| 005 | 20231226010912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/1744-9987.13885 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1136.xml |
| 035 | |a (DE-627)NLM341059714 | ||
| 035 | |a (NLM)35583180 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Naciri Bennani, Hamza |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cryoglobulinemia and double-filtration plasmapheresis |b Personal experience and literature review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2023 | ||
| 500 | |a Date Revised 12.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis and Japanese Society for Apheresis. | ||
| 520 | |a BACKGROUND: Cryoglobulinemia is defined as the presence of an abnormal immunoglobulin that may be responsible for vasculitis of small-caliber vessels. Apheresis can be used in order to temporarily eliminate circulating cryoglobulins. The aim of this study was to assess the effectiveness of apheresis (double-filtration plasmapheresis-DFPP-) in symptomatic and/or severe cryoglobulinemias | ||
| 520 | |a METHODS: Four male patients presenting cryoglobulinemic vasculitis and who received DFPP sessions were included | ||
| 520 | |a RESULTS: Their mean age was 57 ± 15 years. One patient had hepatitis-C virus (HCV)-related cryoglobulinemia and the other three patients were carriers of an IgM Kappa monoclonal gammopathy. Mean duration of follow-up was 15 ± 2 months. DFPP allowed healing of ulcerative skin lesions in the first patient and remission of nephrotic syndrome in the other patients after a median of 6(5-10) sessions | ||
| 520 | |a CONCLUSION: DFPP can be used safely in cryoglobulinemic-vasculitis and can be considered early to achieve a faster and sustained clinical-biological response | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Waldenström disease | |
| 650 | 4 | |a chronic hepatitis C | |
| 650 | 4 | |a cryoglobulinemia | |
| 650 | 4 | |a double-filtration plasmapheresis | |
| 650 | 4 | |a membranoproliferative glomerulonephritis | |
| 650 | 4 | |a rituximab | |
| 700 | 1 | |a Banza, Augustin Twite |e verfasserin |4 aut | |
| 700 | 1 | |a Terrec, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Noble, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Jouve, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Motte, Lionel |e verfasserin |4 aut | |
| 700 | 1 | |a Malvezzi, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Rostaing, Lionel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy |d 2003 |g 27(2023), 1 vom: 01. Feb., Seite 159-169 |w (DE-627)NLM126443165 |x 1744-9987 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2023 |g number:1 |g day:01 |g month:02 |g pages:159-169 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/1744-9987.13885 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2023 |e 1 |b 01 |c 02 |h 159-169 | ||